Chrome Extension
WeChat Mini Program
Use on ChatGLM

Nilotinib in KIT-driven Advanced Melanoma: Results from the Phase II Single-Arm NICAM Trial.

CELL REPORTS MEDICINE(2024)

Cited 3|Views41
Key words
KIT mutation,tyrosine kinase inhibitor,melanoma,mucosal,acral,liquid biopsy
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined